Firm Event to Attract Over 75 Industry-Leading and Emerging Healthcare Companies
NEW YORK–(BUSINESS WIRE)–BTIG announced today the MedTech, Digital Health, Life Science and Diagnostic Tools Conference will take place on Tuesday, February 13 through Wednesday, February 14, 2024. The firm expects to host over 75 corporate management teams throughout the annual event and will include opportunities for the firm’s institutional investor clients to meet with those management teams in a one-on-one setting.
The conference will be hosted by:
Additionally, Mr. Massaro will be joined by Gabriel Bien-Willner, MD, PhD, Chief Medical Officer of Palmetto GBA and Medical Director of the MolDX (Molecular Diagnostic Services) Program and Brian Carey, JD, Partner at Foley Hoag for the fireside chat, “Biomarker Bills, Reimbursement Uncertainty, and the FDA’s Increasing Oversight of LDTs – Opportunities and Challenges in 2024 and Beyond.”
“Our annual event offers institutional investors and leading healthcare companies the opportunity to connect and explore the latest issues and emerging trends across the industry,” said Ryan Serwin, CFA, Director of Research at BTIG. “We are excited to host the event in Snowbird and eagerly anticipate the engagement and shared insights from our distinguished guests.”
For more information about the conference, please email uscorporateaccess@btig.com. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG representative or log in to research.btig.com. BTIG’s Corporate Access program hosts client events across the consumer, energy and infrastructure, financials, healthcare, real estate and technology sectors.
About BTIG
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities. The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.
Disclaimer: https://www.btig.com/disclaimer.aspx
Contacts
Media:
Bailey Burrows
646.818.9092
bburrows@prosek.com
Vanessa Siderow
212.738.6148
vsiderow@btig.com
The new proprietary cell line development platform combines a robust cell line, transposon technology with…
GRASS VALLEY, CA / ACCESSWIRE / June 4, 2024 / Applied Science, the worldwide leader…
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…
SEATTLE, June 4, 2024 /PRNewswire/ -- AffableBPM, a leader in AI-powered business process automation for…
Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services…